The impact of preoperative chemoradiotherapy on advanced low rectal cancer

Journal of Surgical Oncology

Volumn 102, Issue 7, 2010, Pages 771-777

  Kao, Ping Sheng ^a   Chang, Shih Ching ^a   Wang, Ling Wei ^a   Lee, Rheun Chuan ^a   Liang, Wen Yi ^a   Lin, Tzu Chen ^a   Chen, Wei Shone ^a   Jiang, Jeng Kai ^a   Yang, Shung Haur ^a   Wang, Huann Sheng ^a   Lin, Jen Kou ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

CCRT; chemoradiotherapy; rectal cancer; sphincter preservation; survival

Indexed keywords

FOLINIC ACID; UFT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMORADIOTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; DRUG POTENTIATION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECTUM CANCER;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 78649657605     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21711     Document Type: Article

References (37)

1. Willett CG, Compton CC, Shellito PC, et al.: Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer 1994; 73: 2716-2720.
2. McDermott FT, Hughes ESR, Pihl E, et al.: Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985; 72: 34.
3. McCall JL, Cox MR, Wattchow DA,: Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995; 10: 126-132.
4. Bebenek M, Wojnar A,: Infralevator lymphatic drainage of low-rectal cancers: Preliminary results. Ann Surg Oncol 2009; 23.
5. Miscusi G, Masoni L, Dell'Anna A, et al.: Normal lymphatic drainage of the rectum and the anal canal revealed by lymphoscintigraphy. Coloproctology 1987; 9: 171-174.
6. Cawthorn SJ, Parums DV, Gibbs NM, et al.: Extent of mesorectal spread and involvement of lateral resection as prognostic factors after surgery for rectal cancer. Lancet 1990; 335: 1055-1059.
7. Havenga K, Enker WE, Norstein J, et al.: Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur J Surg Oncol 1999; 25: 368-374.
8. Kapiteijn E, Putter H, van de Velde CJH,: Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 2002; 89: 1142-1149.
9. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 2001; 345: 638-646.
10. Gerard A, Buyse M, Nordlinger B, et al.: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ffinal results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208: 606-614.
11. Reis Neto JA, Quilici FA, Reis JA, Jr.:, A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma: A 10-year randomized trial. Dis Colon Rectum 1989; 32: 702-710.
12. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 255: 1114-1123.
13. Wheeler JMD, Dodds E, Warren BF, et al.: Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: Correlation with rectal cancer regression grade. Dis Colon Rectum 2004; 47: 2025-2031.
14. Enker WE, Merchant N, Cohen AM, et al.: Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 1999; 230: 544-552.
15. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-987.
16. Medical Research Council Rectal Cancer Working Party: Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996; 348: 1605-1610.
17. Higgins GA, Humphrey EW, Dwight RW, et al.: Preoperative radiation and surgery for cancer of the rectum. Cancer 1986; 58: 352-359.
18. Stockholm Colorectal Cancer Study Group: Preoperative short-term radiation therapy in operable rectal carcinoma: A prospective randomized trial. Cancer 1990; 66: 49-55.
19. Goldberg PA, Nicholls RJ, Porter NH, et al.: Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failure. Eur J Cancer 1994; 30: 1602-1606.
20. Wang LW, Yang SH, Lin JK, et al.: Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol 2005; 89: 256-264.
21. Indinnimeo M, Grasso RF, Cicchini C, et al.: Endorectal magnetic resonance imaging in the preoperative staging of rectal tumors. Int Surg 1996; 81: 419-422.
22. Compton CC, Fielding LP, Burgart LJ, et al.: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-994.
23. Camma C, Giunta M, Fiorica F, et al.: Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000; 284: 1008-1015.
24. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-1304.
25. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
26. Crane CH, Skibber JM, Birnbaum EH, et al.: The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003; 57: 84-89.
27. Howard JH, Gonzalez Q, Arnoletti JP, et al.: Prognostic factors and preoperative radiation therapy associated with sphincter preservation in patients with respectable rectal cancer. Am J Surg 2008; 195: 239-243.
28. AmenÃs MC, GarcÃa MN, Ragué JM, et al.: Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group. Clin Transl Oncol 2007; 9: 183-191.
29. Gerard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T 3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
30. Uzcudun AE, Batlle JF, Velasco JC, et al.: Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: Results from a phase II study. Dis Colon Rectum 2002; 45: 1349-1359.
31. Machiels JP, Duck L, Honhon B, et al.: Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study. Ann Oncol 2005; 16: 1898-1905.
32. Chau I, Brown G, Cunningham D, et al.: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-674.
33. Willeke F, Horisberger K, Kraus-Tiefenbacher U, et al.: A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of local advanced rectal cancer. Br J Cancer 2007; 96: 912-917.
34. Aschele C, Friso ML, Pucciarelli S, et al.: A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005; 16: 1140-1146.
35. Stockholm Colorectal Cancer Study Group: Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996; 3: 423-430.
36. Mohiuddin M, Regine WF, John WJ, et al.: Preoperative chemoradiation in fixed distal rectal cancer: Dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000; 46: 883-888.
37. Urso E, Serpentini S, Pucciarelli S, et al.: Complications, functional outcome and quality of life after intensive preoperative cheomradiotherapy for rectal cancer. Eur J Surg Oncol 2006; 32: 1201-1208.